Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 25, 2018
Biosynthesis and Identification of Metabolites of Maraviroc and Their Use in Experiments to Delineate the Relative Contributions of Cytochrome P4503A4 versus 3A5Elaine Tseng, Gwendolyn D Fate, Gregory S Walker, et al.
Pharmaceutical Research|February 12, 2002
Physicochemical characterization and solubility analysis of thalidomide and its N-alkyl analogsColleen Goosen, Timothy J Laing, Plessis Jeanetta du, et al.
Die Pharmazie|January 31, 2002
Intranasal toxicity of selected absorption enhancersN Haffejee, J Du Plessis, D G Müller, et al.
Pharmaceutical Research|May 29, 2012
Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactionsManthena V S Varma, Yurong Lai, Bo Feng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 26, 2024
Projections of Drug-Drug Interactions Caused by Time-Dependent Inhibitors of Cytochrome P450 1A2, 2B6, 2C8, 2C9, 2C19, and 2D6 Using In Vitro Data in Static and Dynamic ModelsElaine Tseng, Jian Lin, Timothy J Strelevitz, et al.
European Journal of Pharmacology|April 22, 1993
The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeysR J Vermeulen, B Drukarch, M C Sahadat, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 1994
The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeysR J Vermeulen, B Drukarch, M C Sahadat, et al.
Chemical Research in Toxicology|May 16, 2006
Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicityAbdul E Mutlib, Theunis C Goosen, Jonathan N Bauman, et al.
Clinical and Translational Science|June 22, 2022
Investigation of CYP3A induction by PF-05251749 in early clinical development: comparison of linear slope physiologically based pharmacokinetic prediction and biomarker responseJian Lin, Francois Gaudreault, Nathaniel Johnson, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 8, 2017
Induction of human cytochrome P450 3A4 by the irreversible myeloperoxidase inactivator PF-06282999 is mediated by the pregnane X receptorJamie E Moscovitz, Zhiwu Lin, Nathaniel Johnson, et al.
Pageof 9